UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 303

Sortiert nach

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.439-451

2021

Volltextzugriff (PDF)

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

Clinical & translational oncology, 2021-10, Vol.23 (10), p.1995-2019

2021

Volltextzugriff (PDF)

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

Annals of oncology, 2018-01, Vol.29 (1), p.119-126

2018

Volltextzugriff (PDF)

Translational research in neuroendocrine tumors: pitfalls and opportunities

Oncogene, 2017-04, Vol.36 (14), p.1899-1907

2017

Volltextzugriff (PDF)

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

Nature communications, 2023-05, Vol.14 (1), p.2973-2973, Article 2973

2023

Volltextzugriff (PDF)

Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors

Cancer and metastasis reviews, 2015-09, Vol.34 (3), p.381-400

2015

Volltextzugriff (PDF)

Identification of proteomic signatures associated with lung cancer and COPD

Journal of proteomics, 2013-08, Vol.89, p.227-237

2013

Volltextzugriff (PDF)

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.988-1000

2021

Volltextzugriff (PDF)

Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

Clinical & translational oncology, 2020-11, Vol.22 (11), p.1976-1991

2020

Volltextzugriff (PDF)

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.367-372

2014

Volltextzugriff (PDF)

Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.345-351

2014

Volltextzugriff (PDF)

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

Neuroendocrinology, 2016-04, Vol.103 (2), p.186-194

2016

Volltextzugriff (PDF)

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1480-1490

2004

Volltextzugriff (PDF)

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5484-5492

2005

Volltextzugriff (PDF)

Systemic chemotherapy in the management of malignant peritoneal mesothelioma

European journal of surgical oncology, 2006-08, Vol.32 (6), p.676-681

2006

Volltextzugriff (PDF)

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Annals of oncology, 2015-09, Vol.26 (9), p.1987-1993

2015

Volltextzugriff (PDF)

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

Clinical & translational oncology, 2014-11, Vol.16 (11), p.942-953

2014

Volltextzugriff (PDF)

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Annals of oncology, 2021-05, Vol.32 (5), p.600-608

2021

Volltextzugriff (PDF)

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

Clinical & translational oncology, 2016-11, Vol.18 (11), p.1072-1081

2016

Volltextzugriff (PDF)

The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications

European journal of cancer (1990), 2019-12, Vol.123, p.118-129

2019

Volltextzugriff (PDF)

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study

Annals of oncology, 2018-03, Vol.29 (3), p.602-609

2018

Volltextzugriff (PDF)

MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD

The European respiratory journal, 2014-06, Vol.43 (6), p.1740-1749

2014

Volltextzugriff (PDF)

SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

Clinical & translational oncology, 2013-12, Vol.15 (12), p.996-1003

2013

Volltextzugriff (PDF)

SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer

Clinical & translational oncology, 2017-02, Vol.19 (2), p.135-148

2017

Volltextzugriff (PDF)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study

Annals of oncology, 2019-01, Vol.30 (1), p.124-131

2019

Volltextzugriff (PDF)

1 – 25 von 303

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(294)

Publikationsform

Artikel
(303)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(129)
Humans
(105)
Oncology
(68)
Male
(52)
Female
(51)
Adult
(43)
Middle Aged
(40)
Aged
(33)
Biological And Medical Sciences
(23)
Chemotherapy
(23)
Medicine
(23)
Medicine & Public Health
(23)
Medical Sciences
(21)
Prognosis
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Endocrinology & Metabolism
(18)
Patients
(18)
Treatment Outcome
(18)
Infectious Diseases
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

Translational research in neuroendocrine tumors: pitfalls and opportunities

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors

Identification of proteomic signatures associated with lung cancer and COPD

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?

Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Systemic chemotherapy in the management of malignant peritoneal mesothelioma

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study

MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD

SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study

Suchergebnisse filtern